â€¢ Therapeutic doses of LMWH or NFH are recommended only
in patients diagnosed with VTE or as a bridging strategy
in patients who already use oral anticoagulants, since the use
of oral anticoagulants can represent significant interference in the antiretroviral
treatment of patients with COVID-19.